Cargando…
Agomelatine, A Potential Multi-Target Treatment Alternative for Insomnia, Depression, and Osteoporosis in Postmenopausal Women: A Hypothetical Model
Insomnia, which is associated with menopausal depression, is a common symptom of menopause. Both symptoms have a common etiology, and can affect each other significantly. Pharmacological interventions, including hypnotics and antidepressants, and non-pharmacological therapies are generally administe...
Autores principales: | Yardimci, Ahmet, Ozdede, Mehmet Ridvan, Kelestimur, Haluk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275877/ https://www.ncbi.nlm.nih.gov/pubmed/34267684 http://dx.doi.org/10.3389/fpsyt.2021.654616 |
Ejemplares similares
-
FRI390 The Effects Of Chronic Asprosin Administration On Ovarian Tissue
por: Kelestimur, Haluk, et al.
Publicado: (2023) -
Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder
por: Huang, Juan, et al.
Publicado: (2023) -
Agomelatine's antiglycoxidative action—In vitro and in silico research and systematic literature review
por: Nesterowicz, Miłosz, et al.
Publicado: (2023) -
A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine
por: Li, Zhe, et al.
Publicado: (2023) -
Agomelatine for postpartum depression and
breastfeeding
por: Xiao, Le
Publicado: (2021)